{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:36:31Z","timestamp":1761093391981,"version":"build-2065373602"},"reference-count":321,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":3821,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2001,8]]},"abstract":"<jats:p>Patients with unstable angina or non\u2010ST segment elevation (non\u2014Q\u2010wave) myocardial infarction are a heterogeneous group with respect to their risk of developing clinically significant adverse events such as subsequent myocardial infarction and death. Recent guidelines promote risk stratification of these patients, targeting high\u2010risk patients for maximal antithrombotic and antiischemic therapy and low\u2010risk patients for early discharge. We reviewed current and future modalities for risk stratification of patients and the predictive value of these methods in context with available pharmacologic agents. Unfortunately, most of the data identifying a particular pharmacologic regimen as beneficial in high\u2010risk patients are retrospectively derived from large trials. Until prospective studies that use markers to guide therapy are available, clinicians should be familiar with the use of these risk markers and their application to the role of a given management strategy, including pharmacologic therapy.<\/jats:p>","DOI":"10.1592\/phco.21.11.954.34527","type":"journal-article","created":{"date-parts":[[2004,6,9]],"date-time":"2004-06-09T05:55:17Z","timestamp":1086760517000},"page":"954-987","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk Stratification in Non\u2010ST Segment Elevation Acute Coronary Syndromes with Special Focus on Recent Guidelines"],"prefix":"10.1002","volume":"21","author":[{"given":"A. Scott","family":"Mathis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parag","family":"Meswani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Spinler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.80.2.410"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.1.613"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.21.2219"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.1.118"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00392-0"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.9.1016"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00889-5"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198608143150703"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201303260502"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201233260406"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201303260506"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.11.2844"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-12-199812150-00010"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1998.v135.90300"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1998.v136.93435"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.13.1619"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.12.1195"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00553-1"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001133420207"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00416-7"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(00)90090-5"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00571-7"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)09233-2"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.1.25"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19035"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.6.749"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199609123351103"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.18.1860"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70455-2"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1999.v137.93029"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1999.v137.90600"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307223290401"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.7.835"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708143370702"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.15.1593"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.106915"},{"key":"e_1_2_1_38_2","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/01.CIR.101.22.2557","article-title":"Predictors of outcome in patients with acute coronary syndromes without persistent ST\u2010segment elevation: results from an international trial of 9461 patients","volume":"101","author":"Boersma E.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808133390704"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00481-6"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00312-4"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2001.113216"},{"key":"e_1_2_1_43_2","first-page":"344A","article-title":"Use of the PURSUIT risk score can provide accurate early risk stratification in a nonselected, community\u2010based population with non\u2010ST\u2010elevation acute myocardial infarction [abstr]","volume":"37","author":"Brilakis E.S.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a015343"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(89)90338-0"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00630-6"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00964-3"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70456-4"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.8.707"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1993.tb00746.x"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00160-5"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00319-7"},{"key":"e_1_2_1_53_2","first-page":"187","volume-title":"Basic skills in interpreting laboratory data","author":"Geraets D.R.","year":"1996"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(85)90957-9"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90793-4"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.3.347"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.6.604"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207163270302"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(00)70070-9"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7052.262"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610313351801"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.18.1853"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00872-3"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00628-8"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00870-X"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.9.1651"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199712043372302"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00766-3"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01040-7"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610313351802"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.8.2053"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00200-8"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/92.10.565"},{"key":"e_1_2_1_74_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/clinchem\/46.4.453","article-title":"Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a thrombolysis in myocardial infarction (TIMI) 11B substudy","volume":"46","author":"Morrow D.A.","year":"2000","journal-title":"Clin Chem"},{"key":"e_1_2_1_75_2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/clinchem\/41.8.1228","article-title":"Metaanalysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart diseases","volume":"41","author":"Wu A.H.B.","year":"1995","journal-title":"Clin Chem"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91270-2"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a015341"},{"key":"e_1_2_1_78_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.2.211"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/41.2.312"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.8.1961"},{"key":"e_1_2_1_81_2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/clinchem\/46.6.817","article-title":"Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury","volume":"46","author":"Gerhardt W.","year":"2000","journal-title":"Clin Chem"},{"key":"e_1_2_1_82_2","first-page":"326A","article-title":"Troponin\u2010T 0.03 \u03bcg\/L is the most appropriate cut\u2010off level between high and low risk acute coronary syndrome patients: prospective verification in a large cohort of placebo patients from the GUSTO\u2010IV ACS study [abstr]","volume":"37","author":"Lindahl B.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_83_2","first-page":"315A","article-title":"Improved risk stratification of patients with unstable angina using a lower than usual cut\u2010off point of troponin T combined with CK\u2010MB measurement [abstr]","volume":"37","author":"Solymoss B.C.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_84_2","first-page":"316A","article-title":"Optimal discriminative value of troponin\u2010I for 6 month cardiac event rate in the evaluation for suspected acute coronary syndromes [abstr]","volume":"37","author":"Roolvink V.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_85_2","first-page":"326A","article-title":"Are there high\u2010risk patients who are troponin negative? Risk stratification with the TIMI risk score in patients with acute coronary syndromes: results from OPUS\u2010TIMI 16 [abstr]","volume":"37","author":"Cannon C.P.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_86_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.19.2004"},{"key":"e_1_2_1_87_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a015467"},{"key":"e_1_2_1_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00080-7"},{"key":"e_1_2_1_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00943-8"},{"key":"e_1_2_1_90_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207"},{"key":"e_1_2_1_91_2","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1999.v137.92261"},{"key":"e_1_2_1_92_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.1.96"},{"key":"e_1_2_1_93_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.13.1813"},{"key":"e_1_2_1_94_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199408183310701"},{"key":"e_1_2_1_95_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.19.1958"},{"key":"e_1_2_1_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00581-7"},{"key":"e_1_2_1_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00490-1"},{"key":"e_1_2_1_98_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.16.2079"},{"key":"e_1_2_1_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00136-3"},{"key":"e_1_2_1_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00574-4"},{"key":"e_1_2_1_101_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.12.4204"},{"key":"e_1_2_1_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00018-8"},{"key":"e_1_2_1_103_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503093321003"},{"key":"e_1_2_1_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07591-5"},{"key":"e_1_2_1_105_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010193431602"},{"key":"e_1_2_1_106_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.4.294"},{"key":"e_1_2_1_107_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.6.605"},{"key":"e_1_2_1_108_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.10.1107"},{"key":"e_1_2_1_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00094-6"},{"key":"e_1_2_1_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10452-9"},{"key":"e_1_2_1_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00514-1"},{"key":"e_1_2_1_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70404-7"},{"key":"e_1_2_1_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00348-4"},{"key":"e_1_2_1_114_2","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/clinchem\/44.8.1855","article-title":"Biochemical markers of the acute coronary syndromes","volume":"44","author":"Christenson R.H.","year":"1998","journal-title":"Clin Chem"},{"key":"e_1_2_1_115_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.25.2883"},{"key":"e_1_2_1_116_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.11.1509"},{"key":"e_1_2_1_117_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.6.614"},{"key":"e_1_2_1_118_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.16.1917"},{"key":"e_1_2_1_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00861-2"},{"key":"e_1_2_1_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00432-3"},{"key":"e_1_2_1_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00779-6"},{"key":"e_1_2_1_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00070-3"},{"key":"e_1_2_1_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00175-8"},{"key":"e_1_2_1_124_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018656530541"},{"key":"e_1_2_1_125_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)00811-0"},{"key":"e_1_2_1_126_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(98)00292-7"},{"key":"e_1_2_1_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00531-7"},{"key":"e_1_2_1_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90102-7"},{"key":"e_1_2_1_129_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00695-1"},{"key":"e_1_2_1_130_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.108823"},{"key":"e_1_2_1_131_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.11.1227"},{"key":"e_1_2_1_132_2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jama.1995.03520260058033","article-title":"Risk stratification in unstable angina: prospective validation of the Braunwald classification","volume":"273","author":"Calvin J.E.","year":"1995","journal-title":"JAMA"},{"key":"e_1_2_1_133_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00009-S"},{"key":"e_1_2_1_134_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540190040027"},{"key":"e_1_2_1_135_2","first-page":"I\u201019","article-title":"Prospective validation of the Braunwald Classification of unstable angina: results from the Thrombolysis in Myocardial Ischemia (TIMI) III Registry [abstr]","volume":"92","author":"Cannon C.P.","year":"1995","journal-title":"Circulation"},{"key":"e_1_2_1_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00140-5"},{"key":"e_1_2_1_137_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00560-8"},{"key":"e_1_2_1_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(98)70209-1"},{"key":"e_1_2_1_139_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00977-3"},{"key":"e_1_2_1_140_2","first-page":"I\u201019","article-title":"Would guidelines change care of elderly patients with unstable angina? [abstr]","volume":"92","author":"Giugliano R.P.","year":"1995","journal-title":"Circulation"},{"key":"e_1_2_1_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00106-5"},{"key":"e_1_2_1_142_2","first-page":"332A","article-title":"The management and investigation of elderly patients with acute coronary syndromes without ST elevation: an evidenced based approach? Results of the Prospective Registry of Acute Ischemic Syndromes in the United Kingdom (PRAIS\u2010UK) [abstr]","volume":"37","author":"Collinson J.R.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_143_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.4.601"},{"key":"e_1_2_1_144_2","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1999.v137.94253"},{"key":"e_1_2_1_145_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.4.1545"},{"key":"e_1_2_1_146_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806183382501"},{"key":"e_1_2_1_147_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11162-X"},{"key":"e_1_2_1_148_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)07349-3"},{"key":"e_1_2_1_149_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02427-2"},{"key":"e_1_2_1_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00540-2"},{"key":"e_1_2_1_151_2","unstructured":"Cannon C.P..TACTICS\u2014TIMI 18 results. Presented at the American Heart Association Scientific Sessions 2000 New Orleans LA November 1215 2000."},{"key":"e_1_2_1_152_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1998.1480"},{"key":"e_1_2_1_153_2","first-page":"II\u2010753","article-title":"A risk stratification model to predict mortality in non\u2010Q\u2010wave myocardial infarction randomized to an early invasive or conservative management strategy [abstr]","volume":"102","author":"O'Hern M.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_154_2","first-page":"325A","article-title":"Troponin T and I to predict 6\u2010month mortality and relative benefit of invasive vs. conservative strategy in patients with unstable angina: primary results of the TACTICS\u2010TIMI 18 troponin substudy [abstr]","volume":"37","author":"Cannon C.P.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_155_2","first-page":"335A","article-title":"TIMI risk score to predict 6\u2010month mortality, recurrent cardiac events, and relative benefit of invasive vs. conservative strategy in patients with unstable angina: results of the TACTICS\u2010TIMI 18 [abstr]","volume":"37","author":"Cannon C.P.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_156_2","first-page":"315A","article-title":"High\u2010sensitivity C\u2010reactive protein (hs\u2010CRP) to predict 6\u2010month mortality, and relative benefit of invasive vs. conservative strategy in patients with unstable angina: primary results of the TACTICS\u2010TIMI 18 C\u2010reactive protein substudy [abstr]","volume":"37","author":"Cannon C.P.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_157_2","first-page":"I\u2010775","article-title":"Troponin I predicts early need for revascularization in acute coronary syndromes: a TIMI 11B substudy [abstr]","volume":"100","author":"Morrow D.A.","year":"1999","journal-title":"Circulation"},{"key":"e_1_2_1_158_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1999.1986"},{"key":"e_1_2_1_159_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00434-9"},{"key":"e_1_2_1_160_2","first-page":"II\u2010590","article-title":"Coronary angiography in relation to troponin T level in patients with unstable coronary disease a FRISC\u2010II substudy [abstr]","volume":"102","author":"Lagerqvist B.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_161_2","first-page":"II\u2010752","article-title":"Invasive vs noninvasive strategy in relation to troponin T level and ECG findings: a FRISC\u20102 substudy [abstr]","volume":"102","author":"Diderholm E.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_162_2","first-page":"360A","article-title":"Quality of life one year after invasive intervention in unstable coronary artery disease: results from the FRISC II invasive trial [abstr]","volume":"37","author":"Janzon M.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_163_2","first-page":"376A","article-title":"Cost\u2010effectiveness of early invasive treatment in unstable coronary artery disease: a one\u2010year follow\u2010up from the FRISC II invasive trial [abstr]","volume":"37","author":"Janzon M.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_164_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00767-5"},{"key":"e_1_2_1_165_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.5.570"},{"key":"e_1_2_1_166_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00464-7"},{"key":"e_1_2_1_167_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(98)00290-3"},{"key":"e_1_2_1_168_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-9-199905040-00002"},{"key":"e_1_2_1_169_2","first-page":"719","article-title":"Cost\u2010effectiveness of alternative test strategies for the diagnosis of coronary artery disease","volume":"130","author":"Garber A.M.","year":"1999","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_170_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0025-6196(11)62387-2","article-title":"Adjunctive therapies in the treatment of acute coronary syndromes","volume":"76","author":"Miller W.L.","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_1_171_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.10.1206"},{"key":"e_1_2_1_172_2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","article-title":"Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina: a meta\u2010analysis","volume":"276","author":"Oler A.","year":"1996","journal-title":"JAMA"},{"key":"e_1_2_1_173_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207163270301"},{"key":"e_1_2_1_174_2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1055\/s-0038-1648988","article-title":"Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis \u201cin vivo.\u201d","volume":"72","author":"Landolfi R.","year":"1994","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_175_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.7.1929"},{"key":"e_1_2_1_176_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00322-8"},{"key":"e_1_2_1_177_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(98)70170-X"},{"key":"e_1_2_1_178_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.1.17"},{"key":"e_1_2_1_179_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"e_1_2_1_180_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2000.2474"},{"key":"e_1_2_1_181_2","doi-asserted-by":"publisher","DOI":"10.1186\/CVM-2-2-085"},{"key":"e_1_2_1_182_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008855220129"},{"key":"e_1_2_1_183_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018644212794"},{"key":"e_1_2_1_184_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01130-5"},{"key":"e_1_2_1_185_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)80001-W"},{"key":"e_1_2_1_186_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1999.1879"},{"key":"e_1_2_1_187_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.1.61"},{"key":"e_1_2_1_188_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)07350-X"},{"key":"e_1_2_1_189_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.15.1602"},{"key":"e_1_2_1_190_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00808-1"},{"key":"e_1_2_1_191_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199856020-00013"},{"key":"e_1_2_1_192_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809703100212"},{"key":"e_1_2_1_193_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00648-3"},{"key":"e_1_2_1_194_2","first-page":"II\u2010826","article-title":"Effect on mortality by LMW heparin in relation to STT changes and level of troponin T in unstable coronary artery disease: a FRISC II substudy [abstr]","volume":"102","author":"Lindahl B.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_195_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00447-0"},{"key":"e_1_2_1_196_2","first-page":"II\u2010614","article-title":"The protective effects of long\u2010term LMW heparin (dalteparin) treatment in unstable CAD is confined to patients not previously treated with statins [abstr]","volume":"102","author":"Wallentin L.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_197_2","first-page":"II\u2010591","article-title":"Continuous multi\u2010lead ST\u2010monitoring identifies patients with unstable coronary artery disease who benefit from long\u2010term antithrombotic treatment: FRISC\u2010II substudy [abstr]","volume":"102","author":"Lindahl B.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_198_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00915-3"},{"key":"e_1_2_1_199_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2001.113994"},{"key":"e_1_2_1_200_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00942-6"},{"key":"e_1_2_1_201_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008922527826"},{"key":"e_1_2_1_202_2","first-page":"II\u2010589","article-title":"Reduced risk of myocardial infarction at raised fibrinogen levels by long\u2010term treatment with LMW heparin (dalteparin) in unstable CAD [abstr]","volume":"102","author":"Siegbahn A.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_203_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.17.1702"},{"key":"e_1_2_1_204_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(00)90085-1"},{"key":"e_1_2_1_205_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.7.961"},{"key":"e_1_2_1_206_2","first-page":"I\u2010563","article-title":"Safety and efficacy of percutaneous procedures in patients receiving subcutaneous enoxaparin for unstable angina: results of the ESSENCE trial [abstr]","volume":"98","author":"Deutsch E.","year":"1998","journal-title":"Circulation"},{"key":"e_1_2_1_207_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00343-9"},{"key":"e_1_2_1_208_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.5.658"},{"key":"e_1_2_1_209_2","first-page":"A7","article-title":"Anticoagulation requirements for coronary interventions and the role of low molecular weight heparins","volume":"11","author":"Grines C.L.","year":"1999","journal-title":"J Invas Cardiol"},{"key":"e_1_2_1_210_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008943529597"},{"key":"e_1_2_1_211_2","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1999.v138.a102299"},{"key":"e_1_2_1_212_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(99)00171-0"},{"key":"e_1_2_1_213_2","first-page":"II\u2010826","article-title":"Anti\u2010thrombotic combination using tirofiban and enoxaparin: the ACUTE II study [abstr]","volume":"102","author":"Cohen M.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_214_2","first-page":"II\u2010591","article-title":"The promise of combined LMW heparin and platelet glycoprotein IIb\/IIIa inhibition: results from PARAGON B [abstr]","volume":"102","author":"Mukerjee D.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_215_2","first-page":"F12","article-title":"Antithrombotic therapy in the catheterization laboratory: interim analysis of the NICE trials","volume":"2","author":"Grines C.L.","year":"2000","journal-title":"Eur Heart J"},{"key":"e_1_2_1_216_2","first-page":"365A","article-title":"The use of enoxaparin and IIb\/IIIa antagonists in acute coronary syndromes, including PCI: final results of the NICE 3 study [abstr]","volume":"37","author":"Ferguson J.J.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_217_2","first-page":"336A","article-title":"Safety of abciximab in addition to the LMW heparin dalteparin as the primary treatment of acute coronary syndromes (ACS) [abstr]","volume":"37","author":"James S.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_218_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2001.113217"},{"key":"e_1_2_1_219_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.4.1631"},{"key":"e_1_2_1_220_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.4.1557"},{"key":"e_1_2_1_221_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.4.1495"},{"key":"e_1_2_1_222_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90179-G"},{"key":"e_1_2_1_223_2","first-page":"727","article-title":"Hirulog in the treatment of unstable angina: results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial","volume":"92","author":"Fuchs J.","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_224_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509213331204"},{"key":"e_1_2_1_225_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.20.2049"},{"key":"e_1_2_1_226_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.3.769"},{"key":"e_1_2_1_227_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07332-2"},{"key":"e_1_2_1_228_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-996139"},{"key":"e_1_2_1_229_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.10.1479"},{"key":"e_1_2_1_230_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.10.2389"},{"key":"e_1_2_1_231_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90222-M"},{"key":"e_1_2_1_232_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90223-N"},{"key":"e_1_2_1_233_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01143-3"},{"key":"e_1_2_1_234_2","first-page":"47","article-title":"Heparin\u2010induced thrombo\u2010cytopenia: diagnostic and therapeutic considerations","volume":"7","author":"Matthai W.H.","year":"2000","journal-title":"J Clin Outcomes Manage"},{"key":"e_1_2_1_235_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199448040-00007"},{"key":"e_1_2_1_236_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199856060-00017"},{"key":"e_1_2_1_237_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199957030-00015"},{"key":"e_1_2_1_238_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00554-4"},{"key":"e_1_2_1_239_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.2.596"},{"key":"e_1_2_1_240_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404073301402"},{"key":"e_1_2_1_241_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90007-8"},{"key":"e_1_2_1_242_2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.1997.03550060055036","article-title":"Long\u2010term protection from myocardial events in a randomized trial of brief integrin \u03b23 blockade with percutaneous coronary intervention","volume":"278","author":"Topol E.J.","year":"1997","journal-title":"JAMA"},{"key":"e_1_2_1_243_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199706123362401"},{"key":"e_1_2_1_244_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.15.1951"},{"key":"e_1_2_1_245_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","article-title":"Randomised placebo\u2010controlled and balloon\u2010angioplasty\u2014controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb\/IIIa blockade","volume":"352","author":"The EPISTENT Investigators","year":"1998","journal-title":"Lancet"},{"key":"e_1_2_1_246_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907293410503"},{"key":"e_1_2_1_247_2","first-page":"326A","article-title":"No beneficial effect of 24\u201348 hours abciximab infusion in aspirin and heparin treated acute coronary syndrome patients with elevated troponin without early revascularization procedures: a GUSTO\u2010IV ACS substudy [abstr]","volume":"37","author":"James S.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_248_2","first-page":"365A","article-title":"Glycoprotein IIb\/IIIa inhibitors in the medical management of unstable ischemic syndromes without persistent ST segment elevation: a meta\u2010analysis of the randomized trials [abstr]","volume":"37","author":"Roffi M.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_249_2","first-page":"366A","article-title":"Lack of beneficial effect of intravenous glycoprotein IIb\/IIIa platelet receptor inhibitors in patients with acute coronary syndromes: time to reconsider their routine use and need for a mortality trial [abstr]","volume":"37","author":"Thadani U.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_250_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)10018-7"},{"key":"e_1_2_1_251_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00110-1"},{"key":"e_1_2_1_252_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.14.1358"},{"key":"e_1_2_1_253_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.19.1912"},{"key":"e_1_2_1_254_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00650-6"},{"key":"e_1_2_1_255_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.25.2477"},{"key":"e_1_2_1_256_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905273402103"},{"key":"e_1_2_1_257_2","first-page":"II\u2010330","article-title":"Abciximab suppresses the rise in plasma levels of inflammatory markers following PTCA [abstr]","volume":"102","author":"Lincoff A.M.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_258_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00746-4"},{"key":"e_1_2_1_259_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.4.392"},{"key":"e_1_2_1_260_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.4.629"},{"key":"e_1_2_1_261_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17336"},{"key":"e_1_2_1_262_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(98)70302-3"},{"key":"e_1_2_1_263_2","doi-asserted-by":"publisher","DOI":"10.1053\/hj.1999.v138.99079"},{"key":"e_1_2_1_264_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.13.1086.31592"},{"key":"e_1_2_1_265_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(97)01299-X"},{"key":"e_1_2_1_266_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.5.1445"},{"key":"e_1_2_1_267_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00192-2"},{"key":"e_1_2_1_268_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382102"},{"key":"e_1_2_1_269_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199805213382103"},{"key":"e_1_2_1_270_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10172-0"},{"key":"e_1_2_1_271_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03400-0"},{"key":"e_1_2_1_272_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.20.2045"},{"key":"e_1_2_1_273_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)00722-0"},{"key":"e_1_2_1_274_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.15.1609"},{"key":"e_1_2_1_275_2","first-page":"392A","article-title":"Factors influencing outcome and degree of benefit with GP IIb\/IIIa inhibition in patients with non\u2010ST\u2010elevation acute coronary syndrome [abstr]","volume":"35","author":"Sabatine M.S.","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_276_2","first-page":"344A","article-title":"An integrated clinical approach to predicting the benefit of tirofiban: application of the TIMI risk score for unstable angina\/non\u2010ST elevation MI in PRISM\u2010PLUS [abstr]","volume":"37","author":"Morrow D.A.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_277_2","first-page":"330A","article-title":"Rise in C\u2010reactive protein levels is suppressed with tirofiban + heparin but not with heparin alone in patients with unstable angina\/non\u2010Q\u2010wave myocardial infarction [abstr]","volume":"33","author":"Theroux P.","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_278_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)10285-X"},{"key":"e_1_2_1_279_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01068-7"},{"key":"e_1_2_1_280_2","first-page":"393A","article-title":"Costs and effectivity of treatment with tirofiban in patients with unstable angina\u2010 results from the PRISM trial [abstr]","volume":"35","author":"Heeschen C.","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_281_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1999.1526"},{"key":"e_1_2_1_282_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.20.2466"},{"key":"e_1_2_1_283_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00309-5"},{"key":"e_1_2_1_284_2","unstructured":"TARGET Trial Investigators.Do tirofiban and ReoPro give similar efficacy outcomes trial. Presented at the American Heart Association Scientific Sessions 2000 New Orleans LA November 1215 2000."},{"key":"e_1_2_1_285_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00049-1"},{"key":"e_1_2_1_286_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(00)90089-9"},{"key":"e_1_2_1_287_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(00)90018-8"},{"key":"e_1_2_1_288_2","first-page":"I\u2010433","article-title":"Enhanced efficacy of eptifibatide pre\u2010treatment in patients with acute coronary syndromes undergoing in\u2010hospital coronary artery bypass surgery [abstr]","volume":"100","author":"Marso S.P.","year":"1999","journal-title":"Circulation"},{"key":"e_1_2_1_289_2","first-page":"I\u2010640","article-title":"Impact of diabetes mellitus on outcome in non\u2010ST elevation myocardial infarction and unstable angina: is there a benefit from treatment with eptifibatide [abstr]?","volume":"100","author":"Wright R.S.","year":"1999","journal-title":"Circulation"},{"key":"e_1_2_1_290_2","first-page":"331A","article-title":"Eptifibatide reduces the size and incidence of myocardial infarction in patients with non\u2010ST\u2010elevation acute coronary syndromes [abstr]","volume":"33","author":"Alexander J.H.","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_291_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.7.751"},{"key":"e_1_2_1_292_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.10.1093"},{"key":"e_1_2_1_293_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.10.1101"},{"key":"e_1_2_1_294_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00814-7"},{"key":"e_1_2_1_295_2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/01.CIR.101.4.366","article-title":"Cost\u2010effectiveness of platelet glycoprotein IIb\/IIIa inhibition with eptifibatide in patients with non\u2010ST\u2010elevation acute coronary syndromes","volume":"101","author":"Mark D.B.","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_1_296_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2001.113391"},{"key":"e_1_2_1_297_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90213-K"},{"key":"e_1_2_1_298_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(00)90033-4"},{"key":"e_1_2_1_299_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.9.839"},{"key":"e_1_2_1_300_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.3.230"},{"key":"e_1_2_1_301_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)76154-7"},{"key":"e_1_2_1_302_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66951-6"},{"key":"e_1_2_1_303_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)75195-3"},{"key":"e_1_2_1_304_2","first-page":"244A","article-title":"Therapy with statin agents but not LDL or HDL levels is associated with future survival at coronary artery disease diagnosis, especially in the presence of high C\u2010reactive protein [abstr]","volume":"33","author":"Home B.D.","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_305_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.15.1933"},{"key":"e_1_2_1_306_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.25.3227"},{"key":"e_1_2_1_307_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.19.2088"},{"key":"e_1_2_1_308_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.15.1933"},{"key":"e_1_2_1_309_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03257-8"},{"key":"e_1_2_1_310_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04257-4"},{"key":"e_1_2_1_311_2","first-page":"334A","article-title":"Early statin therapy is associated with markedly lower mortality in patients with acute coronary syndromes: observations from OPUS\u2010TIMI 16 [abstr]","volume":"37","author":"Cannon C.P.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_312_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.13.1711"},{"key":"e_1_2_1_313_2","first-page":"317A","article-title":"Early use of \u03b2\u2010blockers is associated with an attenuation of serum C\u2010reactive protein elevation and a favorable short\u2010term prognosis after myocardial infarction [abstr]","volume":"37","author":"Anzai T.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_314_2","first-page":"335A","article-title":"The effects of \u03b2\u2010blocker therapy in patients with acute coronary syndromes undergoing percutaneous intervention: EPIC, CAPTURE, and RAPPORT databases [abstr]","volume":"37","author":"Ellis B.K.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_315_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200001203420301"},{"key":"e_1_2_1_316_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.15.1667"},{"key":"e_1_2_1_317_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.6.624"},{"key":"e_1_2_1_318_2","first-page":"28A","article-title":"ADP\u2010antagonists therapy added to aspirin prior to coronary intervention markedly attenuates the risk associated with baseline CRP status [abstr]","volume":"37","author":"Robbins M.A.","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_319_2","first-page":"465","article-title":"Effects of long\u2010term, moderate\u2014intensity oral anticoagulation in addition to aspirin in unstable angina","volume":"37","author":"The OASIS Investigators","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_320_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70329-7"},{"key":"e_1_2_1_321_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.103741"},{"key":"e_1_2_1_322_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.14.1832"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.21.11.954.34527","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.21.11.954.34527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:25:50Z","timestamp":1761045950000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.21.11.954.34527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":321,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["10.1592\/phco.21.11.954.34527"],"URL":"https:\/\/doi.org\/10.1592\/phco.21.11.954.34527","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2001,8]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}